Maheshi Ramasamy
Senior Clinical Researcher
Dr Maheshi Ramasamy obtained her medical degree at Christ's College, University of Cambridge. She trained in Infectious Diseases and General Internal Medicine and obtained a DPhil at Wadham College, University of Oxford investigating B cell responses to conjugate and polysaccharide meningococcal vaccines.
As a Principal Investigator at the Oxford Vaccine Group, she leads on adult clinical vaccine trials and her research interest is in adaptive immune responses to vaccines.
She is a Consultant Physician at the Oxford University Hospitals NHS Foundation Trust and is an Honorary Senior Clinical Lecturer at the University of Oxford.
Recent publications
-
An exploratory analysis of the response to ChAdOx1 nCoV-19 (AZD1222) vaccine in males and females.
Journal article
Marchevsky NG. et al, (2022), EBioMedicine, 81
-
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.
Journal article
Shaw RH. et al, (2022), Lancet Respir Med
-
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
-
Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR.
Journal article
Ratcliff J. et al, (2022), Journal of clinical microbiology, e0228321 - e0228321